ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
godiva
|
1.7K |
1.0M |
33 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
1.7K
|
1.0M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Receives Orphan Drug Designation for VAXINIA
|
|
godiva
|
369 |
131K |
25 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
369
|
131K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Receives Orphan Drug Designation for VAXINIA
|
|
godiva
|
369 |
131K |
38 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
369
|
131K
|
38
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
godiva
|
26K |
13M |
44 |
17/09/24 |
17/09/24 |
ASX - By Stock
|
26K
|
13M
|
44
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Webinar - Azer-cel Trial Update
|
|
godiva
|
189 |
83K |
24 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
189
|
83K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
3 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
10 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
6 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
27 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
27
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
14 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
14 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
godiva
|
394 |
184K |
50 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
50
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4E and Annual Report
|
|
godiva
|
131 |
55K |
17 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
131
|
55K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4E and Annual Report
|
|
godiva
|
131 |
55K |
13 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
131
|
55K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4E and Annual Report
|
|
godiva
|
131 |
55K |
10 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
131
|
55K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
3 |
30/08/24 |
30/08/24 |
Charts
|
34K
|
17M
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
9 |
30/08/24 |
30/08/24 |
Charts
|
34K
|
17M
|
9
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
13 |
29/08/24 |
29/08/24 |
Charts
|
34K
|
17M
|
13
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
8 |
29/08/24 |
29/08/24 |
Charts
|
34K
|
17M
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
5 |
29/08/24 |
29/08/24 |
Charts
|
34K
|
17M
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
6 |
29/08/24 |
29/08/24 |
Charts
|
34K
|
17M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
5 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
15K
|
7.4M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
4 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
15K
|
7.4M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
godiva
|
26K |
13M |
7 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
26K
|
13M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
godiva
|
26K |
13M |
23 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
26K
|
13M
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
godiva
|
26K |
13M |
22 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
26K
|
13M
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
godiva
|
26K |
13M |
21 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
26K
|
13M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
godiva
|
97 |
35K |
14 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
97
|
35K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
10
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
godiva
|
30 |
12K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
12K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
31 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
31
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
33 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
33
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
godiva
|
24 |
5.5K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
24
|
5.5K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
godiva
|
24 |
5.5K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
24
|
5.5K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
9 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
32 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
32
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patient dosed in Phase 1 bile tract cancer trial
|
|
godiva
|
133 |
74K |
42 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
133
|
74K
|
42
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
33 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
36 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
36
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patient dosed in Phase 1 bile tract cancer trial
|
|
godiva
|
133 |
74K |
70 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
133
|
74K
|
70
|
|
ASX - By Stock
|
IMU |
Re:
IMU is "NOT " a muli bagger
|
|
godiva
|
73 |
31K |
8 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
73
|
31K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
IMU is "NOT " a muli bagger
|
|
godiva
|
73 |
31K |
3 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
73
|
31K
|
3
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
godiva
|
86 |
32K |
9 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
32K
|
9
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
godiva
|
34K |
17M |
4 |
04/07/24 |
04/07/24 |
Charts
|
34K
|
17M
|
4
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
godiva
|
86 |
32K |
24 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
32K
|
24
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
godiva
|
214 |
64K |
0 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
214
|
64K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
12 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
10 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
godiva
|
15K |
7.4M |
3 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
15K
|
7.4M
|
3
|
|